Beyond Frontline Therapy With Abiraterone and Enzalutamide in mCRPC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study
Clin Genitourin Cancer 2021 Dec 01;19(6)480-490, ND Shore, R Ionescu-Ittu, F Laliberté, L Yang, D Lejeune, L Yu, MS Duh, M Mahendran, J Kim, SR GhateFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.